Nanomedicine · 2018 · 44 citations · 41 references
PharmacyDermatologyPharmaceuticsDrug DeliveryNanoparticle Drug DeliveryPharmaceutical FormulationDrug EncapsulationNanocarriers For TherapeuticsNanomedicineSkin InfectionsTopical PreparationsTransdermal FormulationsCandida Albicans InfectionCutaneous CandidiasisMacromolecule Skin PermeationOil-in-water Emulsion SystemsSkin Penetration MechanismsTopical Antifungal AgentsTopical AntifungalsTopical Antimicrobial Agents
AIM: Ebselen (Eb) is an example of a repurposed drug with poor aqueous solubility which requires sophisticated delivery system such as nanoencapsulation in nanocapsules for topical application. MATERIALS & METHODS: Eb-nanocapsules were examined for morphology, activity against Candida spp., cytotoxicity and skin permeation. RESULTS: Eb-nanocapsules were active against skin-infecting Candida tropicalis, Candida albicans and Candida parapsilosis yeasts (minimal inhibitory concentration values were about 4-, 2- and 1.25-times lower vs free Eb, respectively) and able to suppress induced lipid oxidation in the oil/water emulsion. Moreover, demonstrated minimal toxicity in normal human dermal fibroblast cell line, whereas ex vivo skin permeation studies showed no transdermal passage and strong interactions with stratum corneum. CONCLUSION: Eb-nanocapsules represent a promising, safe and complementary alternative to the treatment of cutaneous candidiasis.
41
Biological interactions between polysaccharides and divalent cations: The egg‐box model
Gregor T. Grant, Edwin R. Morris, David A. Rees et al. · FEBS Letters · 1973 · 2.8K citations · Full text
Can you teach old drugs new tricks?
Nicola Nosengo · Nature · 2016 · 731 citations · Full text